Clinical Trial Update: Study of Clinical Efficacy and Safety of Tosedostat in MDS [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of tosedostat in myelodysplastic syndrome has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Tosedostat (tosedostat)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-06-12